Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • After-Hours Center
  • General
  • News
  • Social Media

Twitter Will Show Verified Phone Numbers: Is This A Move To Please Elon Musk?

By Chris Katje
August 24, 5:05 PM
Social media platform Twitter Inc (NYSE: TWTR) has more than 200 million users but continued to be the subject of accusations of fake accounts. Could more verification tools show off which users are real and not bots?

TSLA

Read More
5 minute read
  • Biotech
  • General
  • News

BioMarin Pharmaceutical Says European Commission Has Granted Conditional Marketing Authorization To ROCTAVIAN Gene Therapy

By Michael Horton
August 24, 4:40 PM
Maintains Orphan Drug Designation (ODD) in the EU Providing 10-years of Market Exclusivity Significant Benefit Over Existing Therapies for Patients with Severe Hemophilia A in EU Based on EMA Determination of

BMRN

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

ERYTECH Pharma Shares Down 34.7% After Co. Announced It Will Stop Further Plans To Pursue BLA Seeking Approval For Graspa In Hypersensitive ALL

By Bill Haddad
August 24, 4:40 PM
ERYTECH to stop further plans to pursue a BLA submission seeking an approval for Graspa® in hypersensitive ALL Evaluation of strategic partnering options ongoing   Cambridge, MA (U.S.) and Lyon (France),

ERYP

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Health Care
  • News

What This Analyst Expects From Cooper Companies Q3 Earnings

By Vandana Singh
August 24, 3:39 PM
Needham expects Cooper Companies Inc (NYSE: COO) to miss F3Q22 consensus revenue and EPS estimates due to unfavorable currency, lockdowns in China, and incremental interest expense when it releases earnings next week. 

COO

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • General
  • Health Care
  • News

One Analyst Is Bullish On Medtronic, Another Is Not Post Q1 Earnings

By Vandana Singh
August 24, 3:36 PM
Citi says that Medtronic plc (NYSE: MDT) delivered better-than-expected FY1Q23 results, reiterating FY23 guidance despite the ongoing litany of pressures impacting Medtech. 

MDT

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions

By Vandana Singh
August 24, 3:32 PM
In a Reuters report, AstraZeneca Plc's (NASDAQ:

AZN

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Amazon’s Unit Whole Foods Sued Over Beef Marketing Slogan Claiming ‘No Antibiotics’

By Vandana Singh
August 24, 3:30 PM
Amazon Inc's (NASDAQ: AMZN) Whole Foods Market unit is being accused in a lawsuit of falsely marketing beef with the slogan "No Antibiotics, Ever."

AMZN

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • IPOs
  • News
  • Offerings

Neurodevelopment Biotech PaxMedica To Debut On NASDAQ Tomorrow

By Vandana Singh
August 24, 3:27 PM
PaxMedica Inc, a Phase 2 biotech developing therapies for neurodevelopmental disorders, revived its IPO plans to raise up to $9…

PXMD

Read More
2 minute read
  • Education
  • General
  • Government
  • News
  • Politics
  • Top Stories

Biden Lays Out Student Loan Relief Plan: Do You Qualify For Forgiveness?

By Adam Eckert
August 24, 3:19 PM
President Joe Biden on Wednesday announced plans to forgive a portion of federal student debt for qualified borrowers and to extend the loan payment freeze until the end of the year.

NAVI

Read More
1 minute read
  • General
  • Politics

Biden Says Had No Advance Notice Of FBI Plan To Search Mar-a-Lago

By Bill Haddad
August 24, 3:08 PM
-Reuters

SPY

Posts pagination

Previous 1 … 2,198 2,199 2,200 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service